Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 16 Next »

Questions

Concepts

What do you want to do?

🔘 Enrol a new client

🔘 Transfer in a client

🔘 Enrol a Mother into PMTCT program

🔘 Re-enrol a client

166937 Care management plan

Enrolment Date

␣␣-␣␣-␣␣␣␣ 📆

160555 Date enrolled in HIV care

Unique ID

__________________________________

162576 New patient identifier

Other Unique ID

__________________________________

162727 Other facility patient identifier

Entry Point

🔽 Voluntary male circumcision clinic

🔽 Private home-based care

🔽 Adolescent outreach program

🔽 Private Company

🔽 Outreach program

🔽 Community-based organization

🔽 Outpatient department

🔽 Pediatric inpatient service

🔽 Voluntary counseling and testing program

🔽 Maternal and child health program

🔽 Vaccination service

🔽 Nutrition program

🔽 Sex worker outreach program

🔽 Intravenous venous drug user outreach program

🔽 Sexually transmitted infection program/clinic

🔽 Under five clinic

🔽 Tuberculosis treatment program

🔽 Adult inpatient service

160540 Method of enrollment

Entry Point - Other

__________________________________

61011 Free text comment

Population Category

🔘 General population

🔘 Key population

🔘 Priority population

166432 Study population type

Key Population Type

🔘 Intravenous drug user

🔘 Male who has sex with men

🔘 Prisoners

🔘 Sex worker

🔘 Transgender Persons

166433 Target population type

Priority Population Type

🔽 Adolescent Girls & Young Women

🔽 Client of sex worker

🔽 Fisher Folk

🔽 Long-distance truck driver

🔽 Migrant Workers

🔽 Non-intravenous drug user

🔽 Refugee

🔽 Uniformed Forces

🔽 Other

5682506 Priority Population Types

Transfer-In

Transferring Facility

__________________________________

160535 Transferred from location

Start ART Date

␣␣-␣␣-␣␣␣␣ 📆

159599 Antiretroviral treatment start date

Current ART Regimen***CC

🔽 d4T + 3TC + NVP

🔽 TDF + FTC + EFV

🔽 TDF + FTC + DTG

🔽 TDF + 3TC + NVP

🔽 TDF + 3TC + LPV/r

🔽 TDF + 3TC + EFV

🔽 TDF + 3TC + DTG + ETR + DRV + RTV

🔽 TDF + 3TC + DTG + DRV + RTV

🔽 TAF + 3TC + LPV/r

🔽 TAF + 3TC + DTG

🔽 TAF + 3TC + DRV/r

🔽 RAL + 3TC + DRV + RTV + TDF

🔽 RAL + 3TC + DRV + RTV + AZT

🔽 RAL + 3TC + DRV + RTV

🔽 ETV + 3TC + DRV + RTV

🔽 AZT + 3TC + RAL

🔽 AZT + 3TC + NVP

🔽 AZT + 3TC + LPV/r

🔽 AZT + 3TC + EFV

🔽 AZT + 3TC + DTG

🔽 AZT + 3TC + DRV + RTV + RAL

🔽 AZT + 3TC + ATV/r

🔽 ABC + 3TC + RAL

🔽 ABC + 3TC + NVP

🔽 ABC + 3TC + LPV/r

🔽 ABC + 3TC + EFV

🔽 ABC + 3TC + DTG

🔽 ABC + 3TC + DRVr

🔽 ABC + 3TC + DRV+RTV+RAL

🔽 ABC + 3TC + ATVr

HIV_Transfer_In_RegimenPatients Regimen

Date of Enrolment into HIV Care

␣␣-␣␣-␣␣␣␣ 📆

163260 Date of first visit

HIV Diagnosis

Date Confirmed HIV Positive

␣␣-␣␣-␣␣␣␣ 📆

160554 Date of HIV diagnosis

Test Type

🔘 Rapid test for HIV

🔘 HIV DNA polymerase chain reaction

🔘 Unknown

164401 HIV test performed

Previous ARV/HAART Use

Use of Pre Exposure Prophylaxis (PrEP)

🔘 Yes

🔘 No

🔘 Unknown

166655 Pre-exposure prophylaxis (PrEP) regimen

Use of Post-exposure prophylaxis (PEP)***CC

🔘 Yes

🔘 No

🔘 Unknown

164845 Eligible for post-exposure prophylaxis

ART Use for Prevention of Mother to Child Transmission of HIV***CC

🔘 Yes

🔘 No

🔘 Unknown

163532 Mother enrolled in prevention of maternal to child transmission (PMTCT) program

Nucleoside Reverse Transcriptase Inhibitors (NRTIS)***CC

☑️ Zidovudine

☑️ Tenofovir

☑️ Lamivudine

☑️ Emtricitabine

☑️ Abacavir

☑️ Other antiretroviral drug

NRTIS Nucleoside Reverse Transcriptase Inhibitors (NRTIS) ARVs

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)***CC

☑️ Etravirine

☑️ Nevirapine

☑️ Efavirenz

☑️ Other antiretroviral drug

☑️ Unknown

NNRTIS Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) ARVs

Protease Inhibitors (PIS)***CC

☑️ Tipranavir

☑️ Saquinavir

☑️ Ritonavir

☑️ Fosamprenavir

☑️ Darunavir

☑️ Atazanavir

ProteaseInhibitorsProtease Inhibitors (PIS) ARVs

Other HIV Drug Classes

☑️ Raltegravir

☑️ Dolutegravir

☑️ Maraviroc

☑️ Enfuvirtide

☑️ Other antiretroviral drug

☑️ Unknown

1193 Current drugs used

Treatment Supporter

Treatment Supporter Name

__________________________________

160638 Name of treatment supporter

Treatment Supporter Phone Number

__________________________________

160642 Telephone number of treatment supporter

Treatment Supporter Relationship

🔽 Sibling

🔽 Parent

🔽 Partner or spouse

🔽 Guardian

🔽 Grandparent

🔽 Other

160640 Treatment supporter relationship to patient

Re-enrollment

Date of Re-enrollment

␣␣-␣␣-␣␣␣␣ 📆

160753 Date of event

Reason For Re-enrolment

__________________________________

162169 Text of encounter note

  • No labels